Phages are highly specific, naturally occurring viruses that parasitize and kill bacteria. Historically, phages have been used when antibiotics have proven to be either ineffective or where the disease-causing bacteria have become resistant to antibiotics.
GangaGen started as a biotechnology company focused on the development of phages and phage-based products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics. The company retains significant expertise and intellectual property related to phage biology and related technologies.
GangaGen is developing a phage product as an alternative to antibiotics in animal health including Salmonella infections in poultry.
GangaGen also helps biopharmaceutical companies in phage contamination testing of their E. coli host used in bioprocess for the production of therapeutic proteins.
For more information on GangaGen’s phage expertise or to explore opportunities, please Contact Us..